Funing Yan

Funing Yan is a Principal Scientist at Boehringer Ingelheim, with experience in analytical method development and validation for dose formulation analysis, gained from previous roles at Eurofins Lancaster Laboratories and ARMGO Pharma. At Eurofins, responsibilities included designing and conducting GLP studies, while at ARMGO, Funing Yan led analytical method developments for drug characterization and clinical trial sample analyses. Prior experience includes working as a Protein Biochemist at Acorda Therapeutics, where growth factor and antibody characterization was performed, and a research associate position at Albert Einstein College of Medicine, focusing on purification and quantitation methods in drug discovery. Funing Yan holds a Ph.D. in Chemistry from the Illinois Institute of Technology.